E Fund Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-69,431
Closed -$1.69M 427
2024
Q4
$1.69M Hold
69,431
0.08% 122
2024
Q3
$2.58M Sell
69,431
-62,865
-48% -$2.34M 0.13% 78
2024
Q2
$6.3M Hold
132,296
0.35% 32
2024
Q1
$5.06M Hold
132,296
0.31% 33
2023
Q4
$4.13M Sell
132,296
-650,000
-83% -$23.4M 0.26% 31
2023
Q3
$31.4M Sell
782,296
-120,000
-13% -$5.62M 2.39% 9
2023
Q2
$47.4M Hold
902,296
3.75% 5
2023
Q1
$57.7M Hold
902,296
4.21% 6
2022
Q4
$43.8M Buy
902,296
+170,000
+23% +$10.7M 3.64% 4
2022
Q3
$51.7M Hold
732,296
4.81% 3
2022
Q2
$51.9M Buy
732,296
+600,000
+454% +$38.7M 4.7% 5
2022
Q1
$10.6M Hold
132,296
0.35% 22
2021
Q4
$12.1M Hold
132,296
0.43% 20
2021
Q3
$17M Buy
+132,296
New +$18.5M 0.71% 14
2021
Q1
$31.8M Buy
+301,652
New +$30.2M 2.61% 9

Other funds holding STAA

E Fund Management's STAA Position: Q1 2025 in Review

E Fund Management sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 69,431 shares — an estimated $1.69M sold.

E Fund Management first reported a position in STAA in Q1 2021 and held it in 15 quarters. The position peaked at $57.7M in Q1 2023. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • E Fund Management reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • E Fund Management sold 69,431 STAAR Surgical shares in Q1 2025, an estimated $1.69M.
  • E Fund Management first reported a position in STAAR Surgical in Q1 2021 and held it in 15 quarters.
  • E Fund Management's STAAR Surgical position peaked at $57.7M in Q1 2023.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on E Fund Management's 13F filing for Q1 2025, filed 13 May 2025.